{"id":39249,"date":"2026-07-20T10:00:00","date_gmt":"2026-07-20T08:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=d344bebe6cd906b5052ab1e90a9ff0dd"},"modified":"2026-07-20T10:00:00","modified_gmt":"2026-07-20T08:00:00","slug":"galderma-launches-alastin-in-japan-and-key-markets-across-asia-pacific-expanding-its-footprint-in-the-region-2","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=39249","title":{"rendered":"Galderma Launches Alastin\u00ae in Japan and Key Markets Across Asia Pacific, Expanding Its Footprint in the Region"},"content":{"rendered":"<ul class=\"bwlistdisc\">\n<li>\nGalderma launches Alastin, its premium regenerative skincare brand into Japan, Singapore, South Korea and Taiwan<\/li>\n<li>\nThe Japan and Asia Pacific (JPAC) region is among the fastest\u2011growing markets globally for medical aesthetics and dermatological skincare, driven by rising adoption of minimally invasive procedures and an increased focus on skin quality, which are accelerating demand for innovative, science\u2011based skincare solutions such as Alastin<sup>1,2<\/sup><\/li>\n<li>\nThese launches reflect Galderma\u2019s ongoing growth across the JPAC region and long\u2011term commitment to advancing regenerative skincare<\/li>\n<\/ul><p>ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the launch of Alastin \u2013 its premium regenerative skincare brand \u2013 across the JPAC region. The brand recently launched in Taiwan, will soon launch in Japan, and has received approval to launch in Singapore and South Korea, with planned market introduction in September and November, respectively.<\/p><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260719444150\/en\/2854354\/5\/GALDERMA_LOGO_BLACK_RGB.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260719444150\/en\/2854354\/22\/GALDERMA_LOGO_BLACK_RGB.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260719444150\/en\/2854354\/5\/GALDERMA_LOGO_BLACK_RGB.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260719444150\/en\/2854354\/21\/GALDERMA_LOGO_BLACK_RGB.jpg\" \/><\/a><p>\nThis expansion follows Alastin\u2019s recent launches in China and Australia and underscores Galderma\u2019s continued investment in JPAC, a region characterized by advanced skincare practices and rapid growth in injectable aesthetics.<sup>1,2<\/sup> This is increasing demand for integrated skincare solutions that support skin readiness, recovery and long-term quality.<sup>3,4,5<\/sup><\/p><p>\nAlastin addresses this need through its range of peri-procedural support and daily skincare products that amplify the skin\u2019s natural regenerative abilities, supporting recovery and enhances visible outcomes of in-demand aesthetic procedures such as energy-based device and injectable treatments.<sup>6-13<\/sup> Select Alastin products are powered by proprietary TriHex Technology<sup>\u00ae<\/sup>, which uniquely combines peptide components that help clear aged, damaged collagen and elastin while simultaneously supporting the production of new, healthy collagen and elastin \u2013 a dual mechanism that underpins its regenerative approach.<sup>6,7,11,14<\/sup> Restorative Skin Complex with TriHex+\u2122 features the next evolution of this technology, which supports the skin\u2019s natural production of high molecular weight hyaluronic acid (HA), while further enhancing collagen and elastin production, contributing to long-term skin longevity.<sup>15,16<\/sup><\/p><table cellspacing=\"0\" class=\"bwblockalignl bwtablemarginb bwwidth100\">\n<tr>\n<td class=\"bwpadl0 bwwidth100 bwrowaltcolor0\" colspan=\"1\" rowspan=\"1\"><p class=\"bwalignc bwcellpmargin\">\n\u00a0<\/p><p class=\"bwalignc bwcellpmargin\">\n\u201cPatients today expect skincare that goes beyond surface hydration. They seek products that support skin function, renewal, and long-term skin quality. I am pleased to offer Alastin because it complements aesthetic procedures by enhancing the skin's regenerative capacity, supporting recovery, and helping patients achieve healthier, more resilient, and naturally radiant skin.\u201d<\/p><p class=\"bwcellpmargin\">\n\u00a0<\/p><p class=\"bwalignc bwcellpmargin\">\n<b>DR. RIEKO TSUBOUCHI<\/b><\/p><p class=\"bwalignc bwcellpmargin\">\n<b>DERMATOLOGIST AND DIRECTOR OF GINZA SKIN CLINIC<\/b><\/p><p class=\"bwalignc bwcellpmargin\">\n<b>JAPAN<\/b><\/p><p class=\"bwalignc bwcellpmargin\">\n\u00a0<\/p><\/td><\/tr>\n<\/table><p>\n<b>Science-driven skincare heritage with an industry-leading portfolio<\/b><\/p><p>\nWith more than 60 international dermatological publications and over 25 granted patents, Alastin is one of the most clinically studied skincare brands.<sup>17,18<\/sup> In the United States it is the number one peri-procedural option and continues to be one of the fastest-growing global medical aesthetics skincare brands.<sup>19<\/sup> It is powered by a proprietary peptide-based synergistic combination of ingredients and supported by real-world clinical experience demonstrating high levels of patient satisfaction, including improvements in radiance, recovery following procedures, and sustained hydration as well as overall skin resilience.<sup>7-9,11,16,20,21<\/sup><\/p><p>\nThe Alastin Skincare portfolio uses deep regenerative science to push the boundaries of what skincare can do and address a broad spectrum of needs across the aesthetic journey.<sup>8,9 <\/sup>Nine products will be available in the JPAC region, including:<\/p><ul class=\"bwlistdisc\">\n<li>\n<b>Procedure support products<\/b>, Skin Nectar and INhance \u2013 both with TriHex Technology<sup>\u00ae <\/sup>\u2013 developed for peri-procedural use to enhance visible outcomes and reduce recovery time<sup>7,16,20,22-26<\/sup><\/li>\n<li>\n<b>Daily treatment products:<\/b>\n<ul class=\"bwlistcircle\">\n<li>\n<b>Rejuvenate products<\/b>, designed to support ongoing collagen and elastin renewal:<sup>27-29<\/sup> Restorative Skin Complex with TriHex+\u2122, Restorative Eye Complex with TriHex Technology<sup>\u00ae<\/sup>, and Restorative Neck Complex with TriHex Technology<sup>\u00ae<\/sup><\/li>\n<li>\n<b>Targeted serums<\/b> formulated to address specific skin concerns:<sup>30-33<\/sup> C-RADICAL Defense (an antioxidant serum that protects against environmental stressors), A-LUMINATE Brightening Serum\u2122 (reduces the appearance of hyperpigmentation and discoloration for a more even skin tone), and HA IMMERSE Serum\u2122 (enhances skin hydration)<\/li>\n<\/ul><\/li>\n<li>\n<b>Daily care products<\/b> to help moisturize, nourish and soothe skin:<sup>34,35 <\/sup>Ultra Nourishing Moisturizer with TriHex Technology<sup>\u00ae<\/sup><\/li>\n<\/ul><table cellspacing=\"0\" class=\"bwblockalignl bwtablemarginb bwwidth100\">\n<tr>\n<td class=\"bwpadl0 bwwidth100 bwrowaltcolor0\" colspan=\"1\" rowspan=\"1\"><p class=\"bwalignc bwcellpmargin\">\n\u00a0<\/p><p class=\"bwalignc bwcellpmargin\">\n\u201cAlastin sets a new standard in regenerative skincare so we\u2019re excited to bring it to patients and healthcare professionals in the JPAC region, where there is an ever-increasing demand for aesthetic procedures and peri-procedural care. As part of our commitment to delivering holistic regenerative skincare, the Alastin range is carefully curated to work synergistically with our Injectable Aesthetics portfolio, as well as daily skincare maintenance, enabling us to support patients with tailored solutions that address evolving needs.\u201d<\/p><p class=\"bwalignc bwcellpmargin\">\n\u00a0<\/p><p class=\"bwalignc bwcellpmargin\">\n<b>ALAN D. WIDGEROW, MBBCH, MMED, FCS, FACS<\/b><\/p><p class=\"bwalignc bwcellpmargin\">\n<b>CHIEF SCIENTIFIC OFFICER<\/b><\/p><p class=\"bwalignc bwcellpmargin\">\n<b>HEAD OF INNOVATION, DERMATOLOGICAL SKINCARE<\/b><\/p><p class=\"bwalignc bwcellpmargin\">\n<b>GALDERMA<\/b><\/p><p class=\"bwcellpmargin\">\n\u00a0<\/p><\/td><\/tr>\n<\/table><p>\nJPAC is a key growth engine for Galderma. By introducing Alastin, Galderma is expanding access to a holistic regenerative skincare portfolio designed to address some of today\u2019s most significant aesthetic trends and needs, from an increased focus on skin quality and longevity, to growing concerns around menopause-related skin health, medication-driven weight loss, and aging.<\/p><p>\n<b>About<\/b> <b>Alastin<\/b><\/p><p>\nAlastin by Galderma is the leader in peri-procedural regenerative skincare, offering innovative, scientifically proven, and clinically tested products. The Alastin Skincare portfolio provides a comprehensive collection of cutting-edge formulas designed specifically for peri-procedural use, as well as daily skincare regimens, all powered by proprietary peptides and innovative, clinically meaningful, science-backed ingredients designed to amplify the skin\u2019s own natural regenerative abilities. With more than 60 international dermatological publications and over 25 patents granted, Alastin is one of the most clinically studied professional-grade skincare brands.<\/p><p>\n<b>About Galderma<\/b><\/p><p>\nGalderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body\u2019s largest organ \u2013 the skin \u2013 meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.galderma.com%2F&amp;esheet=54572121&amp;newsitemid=20260719444150&amp;lan=en-US&amp;anchor=www.galderma.com&amp;index=1&amp;md5=1def2a58fcef1903dda9771b99de1c3d\" rel=\"nofollow\" shape=\"rect\">www.galderma.com<\/a>.<\/p><p>\n<b>References<\/b><\/p><ol class=\"bwlistdecimal\">\n<li>\nAsia-Pacific emerging as the new 'Mecca' of medical aesthetics. Accessed July 2026. <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.theaestheticguide.com%2Fclinical-marketing%2Fasia-pacific-emerging-as-the-new-mecca-of-medical-aesthetics&amp;esheet=54572121&amp;newsitemid=20260719444150&amp;lan=en-US&amp;anchor=Available+online&amp;index=2&amp;md5=b40791e9ea08a430df312200acb16d4c\" rel=\"nofollow\" shape=\"rect\">Available online<\/a>.<\/li>\n<li>\nAsia Pacific non-invasive aesthetic procedures market size &amp; outlook. Accessed July 2026. <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.grandviewresearch.com%2Fhorizon%2Foutlook%2Fnon-invasive-aesthetic-procedures-market%2Fasia-pacific%3Futm_source%3Dchatgpt.com&amp;esheet=54572121&amp;newsitemid=20260719444150&amp;lan=en-US&amp;anchor=Available+online&amp;index=3&amp;md5=cd0e2630b8fa52e1eca27347cd1364ca\" rel=\"nofollow\" shape=\"rect\">Available online<\/a>.<\/li>\n<li>\nGuidepoint Qsight. From Gen Z to GLP-1s: trends reshaping the medical aesthetics industry. Accessed July 2026. Available <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fqsight.guidepoint.com%2Fblog%2Ftrends-reshaping-the-medical-aesthetics-industry%2F&amp;esheet=54572121&amp;newsitemid=20260719444150&amp;lan=en-US&amp;anchor=online&amp;index=4&amp;md5=4cb964f0601515ae9e32e3a0721c9997\" rel=\"nofollow\" shape=\"rect\">online<\/a>.<\/li>\n<li>\nVerified Market Reports. Preoperative Skin Preparation Market. Accessed July 2026. Available <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.verifiedmarketreports.com%2Fproduct%2Fpreoperative-skin-preparation-market%2F&amp;esheet=54572121&amp;newsitemid=20260719444150&amp;lan=en-US&amp;anchor=online&amp;index=5&amp;md5=bbbf662d509c5bec15d35d5c4afec546\" rel=\"nofollow\" shape=\"rect\">online<\/a>.<\/li>\n<li>\nPW Consulting Health Care Research Center. Post Procedure Skin Care Product Market. Accessed July 2026. Available <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fpmarketresearch.com%2Fhc%2Fpost-procedure-skin-care-product-market%2F&amp;esheet=54572121&amp;newsitemid=20260719444150&amp;lan=en-US&amp;anchor=online&amp;index=6&amp;md5=2f19cbf86e92cbc488f1e66820b1c437\" rel=\"nofollow\" shape=\"rect\">online<\/a>.<\/li>\n<li>\nJalian HR, et al. Enhancing outcomes of procedure pairing with Next Generation Regenerating Skin Nectar with TriHex+ Technology. <i>J Cosmet Dermatol<\/i>. 2025;24(12):e70556. doi:10.1111\/jocd.70556.<\/li>\n<li>\nWidgerow AD, et al. Extracellular matrix modulation: optimizing skin care and rejuvenation procedures.<i> J Drugs Dermaol. <\/i>2016;15(Suppl 4):s63\u201371.<\/li>\n<li>\nSimeon A, et al. Expression and activation of matrix metalloproteinases in wounds: modulation by the Tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. <i>Invest Dermatol<\/i>.1999;112(6):957\u201364. doi: 10.1046\/j.1523-1747.1999.00606.x.<\/li>\n<li>\nWilson MJV, et al. A randomized, single-blinded trial of a Tripeptide\/Hexapeptide healing regimen following laser resurfacing of the face. <i>J Cosmet Dermatol<\/i>. 2017;16(2):217\u2013222. doi:10.1111\/jocd.12339.<\/li>\n<li>\nRobinson DM, Frulla AP. Randomized, Split-face\/d\u00e9collet\u00e9 comparative trial of procedure enhancement system for fractional non-ablative laser resurfacing treatment. <i>J Drugs Dermatol<\/i>. 2017;16(7):707-710.<\/li>\n<li>\nWidgerow AD, Cohen SR, Fagien S. Preoperative skin conditioning: extracellular matrix clearance and skin bed preparation, a new paradigm. <i>Aesthet Surg J.<\/i> 2019;39(Suppl_3):S103-S111. doi: 10.1093\/asj\/sjz022.<\/li>\n<li>\nKilmer, SL, et al. Pre- and post-procedural care best practices to enhance energy-based treatment outcomes. <i>JDD<\/i>.2019 Aug;18(8 Suppl 1):s187-195.<\/li>\n<li>\nMcGuinn KP et al. Combination Tripeptide\/Hexapeptide serum with 1540 nm nonablative fractional laser for the treatment of striae distensae: a pilot study. <i>Skinmed<\/i>. 2020;18(6):337-341. PMID: 33397562.<\/li>\n<li>\nLee WW, et al. A multi-center evaluation of Restorative Eye Treatment and INhance with Trihex Technology to improve aesthetic outcomes when used pre- and post-blepharoplasty. <i>Aesthet Surg J Open Forum<\/i>. 2022;5:ojac089. doi: 10.1093\/asjof\/ojac089.<\/li>\n<li>\nWidgerow AD, Ziegler ME, Shafiq F. TriHex 2.0\u2014advancing skin health science and the TriHex Technology. <i>J Cosmet Dermatol<\/i>. 2024;0:e16690.<\/li>\n<li>\nWidgerow AD, et al<i>. <\/i>Developing a topical adjunct to injectable procedures<i>. J Drugs Dermatol. <\/i>2020;19(4):398\u2013404. doi:10.36849\/JDD.2020.5016.<\/li>\n<li>\nGalderma. Data on File. Alastin Publication List.<\/li>\n<li>\nGalderma. Data on File. Alastin Patent List.<\/li>\n<li>\nGalderma. Data on File. LifeSci Consulting primary market research. 2022.<\/li>\n<li>\nGalderma. Data on File. RD.27.SPR.207064.<\/li>\n<li>\nGalderma. Data on File. RD.27.SPR.207062.<\/li>\n<li>\nLiu Z. Efficacy and safety of a topical skincare regimen with TriHex technology<sup>\u00ae<\/sup>. Poster presented at AMWC 2025; March 27-29, 2025; Monaco.<\/li>\n<li>\nGalderma. Data on File. RD.27.SPR.207069.<\/li>\n<li>\nGalderma. Data on File. RD.27.SPR.207060.<\/li>\n<li>\nWidgerow AD, et al. Advances in pigmentation management: a multipronged approach.<i> J Drugs Dermatol. <\/i>2022;21(11):1206\u201320. doi:10.36849\/JDD.7013<\/li>\n<li>\nCalame A, Widgerow AD. Histological changes associated with extracellular matrix-remodeling topical therapy. <i>Derm Case Rep<\/i>. 2017;2(2):1000126.<\/li>\n<li>\nWidgerow AD, et al. So let\u2019s design a peptide . . . a physician\u2019s approach. <i>J Drugs Dermatol<\/i>. 2024;23(5):347-352. doi:10.36849\/JDD.7921<\/li>\n<li>\nNelson AM, Ortiz, AE. A Tripeptide\/Hexapeptide anti-aging regimen that targets both collagen and elastin, and improves both physician and subject scoring of facial aesthetics. <i>Dermatol Case Rep<\/i>. 2018;3(1). doi:10.35248\/2684-124X.18.3.139<\/li>\n<li>\nWidgerow AD, Jiang LI, Calame A. A single-center clinical trial to evaluate the efficacy of an tripeptide\/hexapeptide antiaging regimen. <i>J Cosmet Dermatol<\/i>. 2019;18(1)176\u2013182. doi: 10.1111\/jocd.12507<\/li>\n<li>\nWang JV et al. A multi-center, randomized, blinded clinical study evaluating the efficacy and safety of a novel topical product for facial dyschromia. <i>J Drugs Dermatol.<\/i> 2023;22(4):333-338. doi:10.36849\/JDD.7340<\/li>\n<li>\nMoradi A et al. Multi-center evaluation of a topical antioxidant serum. <i>J Cosmet Dermatol<\/i>. 2024;23(1):145-153. doi: 10.1111\/jocd.16067.<\/li>\n<li>\nWidgerow AD et al. Antioxidants with proven efficacy and elastin-conserving vitamin C - A new approach to free radical defense. <i>J Cosmet Dermatol<\/i>. 2023 Dec;22(12):3320-3328. doi: 10.1111\/jocd.15999.<\/li>\n<li>\nRobinson DM, et al. Multicenter evaluation of a topical hyaluronic acid serum. <i>J Cosmet Dermatol.<\/i> 2022;21(9):3848-38 58. doi: 10.1111\/jocd.15241.<\/li>\n<li>\nGalderma. Data on File. RD.27.SPR-206851.<\/li>\n<li>\nAllais B, Friedman A. Colloidal Oatmeal Part I: History, Basic Science, Mechanism of Action, and Clinical Efficacy in the Treatment of Atopic Dermatitis. <i>J Drugs Dermatol<\/i>. 2020;19(10):s4-s7<\/li>\n<\/ol><br\/> <b>Contacts<\/b> <br\/><p>\n<b>For further information:<\/b><\/p><p>\nChristian Marcoux, M.Sc.\n<br\/>Chief Communications Officer\n<br\/><a  href=\"mailto:christian.marcoux@galderma.com\" rel=\"nofollow\" shape=\"rect\">christian.marcoux@galderma.com<\/a><br\/>+41 76 315 26 50<\/p><p>\nRichard Harbinson\n<br\/>Corporate Communications Director\n<br\/><a  href=\"mailto:richard.harbinson@galderma.com\" rel=\"nofollow\" shape=\"rect\">richard.harbinson@galderma.com<\/a><br\/>+41 76 210 60 62<\/p><p>\nC\u00e9line Buguet\n<br\/>Franchises and R&amp;D Communications Director\n<br\/><a  href=\"mailto:celine.buguet@galderma.com\" rel=\"nofollow\" shape=\"rect\">celine.buguet@galderma.com<\/a><br\/>+41 76 249 90 87<\/p><p>\nEmil Ivanov\n<br\/>Head of Strategy, Investor Relations, and ESG\n<br\/><a  href=\"mailto:emil.ivanov@galderma.com\" rel=\"nofollow\" shape=\"rect\">emil.ivanov@galderma.com<\/a><br\/>+41 21 642 78 12<\/p><p>\nJessica Cohen\n<br\/>Investor Relations and Strategy Director\n<br\/><a  href=\"mailto:jessica.cohen@galderma.com\" rel=\"nofollow\" shape=\"rect\">jessica.cohen@galderma.com<\/a><br\/>+41 21 642 76 43<\/p>","protected":false},"excerpt":{"rendered":"<p>Galderma launches Alastin, its premium regenerative skincare brand into Japan, Singapore, South Korea and Taiwan<\/p>\n<p>The Japan and Asia Pacific (JPAC) region is among the fastest\u2011growing markets globally for medical aesthetics and dermatological skincar&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-39249","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/39249","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=39249"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/39249\/revisions"}],"predecessor-version":[{"id":39251,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/39249\/revisions\/39251"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=39249"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=39249"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=39249"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}